MLKL and arthritic joint disease: Considering IAPs regulate RIPK3 activity, and suppress K/B × N arthritis severity, we sought to determine if a TLR–TRIF–RIPK3 axis could regulate K/B × N arthritis via caspase-8 or MLKL signalling.